StonvexLoading…
StonvexStonvexStonvexCore line items from RNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.85B | $11.70B | $9.13B | $5.06B |
Operating Income | $4.01B | $2.99B | $3.11B | $-1.22B |
Net Income | $2.68B | $1.87B | $2.56B | $-1.06B |
EPS (Diluted) | $56.03 | $35.21 | $52.27 | $-25.50 |
Total Assets | $53.80B | $50.71B | $49.01B | $36.55B |
Total Liabilities | $34.59B | $33.16B | $33.45B | $26.69B |
Cash & Equivalents | $1.73B | $1.68B | $1.88B | $1.19B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 43.96M | 50.18M | 52.69M | 43.72M |